Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100584827C discloses efficient synthesis of chiral ligands from L-prolinol or ephedrine. High yield, room temperature reaction, and superior enantioselectivity for pharmaceutical intermediates.
Patent CN106866574A reveals palladium-catalyzed asymmetric reductive amination for high-purity chiral sulfonamides, offering supply chain reliability and cost efficiency.
Patent CN109111380B introduces a transition-metal-free method for synthesizing chiral amines via hydrogen borrowing, offering cost reduction in API manufacturing and high stereoselectivity.
Patent CN112209965A details a high-yield rhodium-catalyzed asymmetric hydrogenation route for chiral beta-aminophosphine precursors, offering significant supply chain and cost advantages.
Patent CN109134402A reveals efficient one-step synthesis technology. Offers significant cost reduction and supply reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN114989058B reveals a metal-free catalytic route for high-purity chiral chlorosulfoximines, offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN102174006A details a novel chiral hydroxyl amide synthesis using copper acetate, offering high conversion rates for pharmaceutical intermediate manufacturing.
Patent CN103951588A reveals a novel chiral squaramide catalytic route for saxagliptin intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101801984A details novel chiral phosphoramides and N-phosphonimines. Discover stable alternatives to N-sulfinylimines for cost-effective asymmetric synthesis.
Patent CN118638038A reveals mild catalytic synthesis for high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability advantages.
Patent CN101569864B details a novel chiral sulfonamide catalyst enabling high-yield asymmetric conjugate addition, offering a metal-free alternative for pharmaceutical manufacturing.
Novel patent CN118221686A details efficient chiral triazole synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN114436912A reveals a cinchona-catalyzed route for carbon-nitrogen axis chiral sulfonamides. Achieves high enantioselectivity and yield under mild conditions for cost-effective manufacturing.
Discover advanced chiral bisphosphonamide compounds for asymmetric catalysis. Reliable supplier offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Patent CN116041216A reveals a high-yield Pd-catalyzed asymmetric C-H arylation method. This breakthrough offers reliable pharmaceutical intermediate suppliers a scalable route for chiral amides with superior enantioselectivity.
Novel quinine-catalyzed route for chiral sulfinamides. High purity, mild conditions, scalable for pharma intermediates. Reliable supply chain solutions.
Patent CN102898342A details a novel chiral hydroxyl amide synthesis offering 99% conversion in catalysis. Discover cost-effective manufacturing and supply advantages.
Patent CN114276280B reveals enzymatic route for chiral sulfonamide. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.